Company Summary
Search
Home Page
 
*Tetra Bio-Pharma Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
November 30DelistN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
17/May/2007 3/Aug/2020 Canada   
Exchange Filing Office
Location
(not available)
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  *Research and Development of Pharmaceutical Products  (not available) 
Securities
SymbolSecurity NameMarketStatus
*TBP*Tetra Bio-Pharma Inc.TSX VentureDELIST
*TBP.WT*Tetra Bio-Pharma Inc. wt ex 05Mar2021TSX VentureDELIST
*TBP.WT.A*Tetra Bio-Pharma Inc wt 12jul2022 TSX VentureDELIST
*TBP.WT.B*Tetra Bio-Pharma Inc wt 13Feb2023TSX VentureDELIST
Name HistoryFromTo
*Tetra Bio-Pharma Inc.16/Mar/20173/Aug/2020
Company Facts Reconciliation
SubjectDate Returned
(not available)
Associations
Auditing Firm:  *UHY McGovern Hurley LLP
Transfer Agent:  *Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  30/Jul/2020  NEWS RELEASE - TETRA BIO-PHARMA ANNOUNCES EXPECTED EFFECTIVE DATE OF LISTING ON TSX OF ITS COMMON SHARES AND WARRANTS[CANADA NEWSWIRE]
    NEWS RELEASE - TETRA AND MONDIAS JOINTLY ANNOUNCE THE ACQUISITION OF TETRA'S SUBSIDIARY LUMIERA BY MONDIAS TO CREATE A NEW GROWTH PLATFORM[CANADA NEWSWIRE]
    NEWS RELEASE - TETRA BIO-PHARMA ANNOUNCES CLOSING OF PUBLIC OFFERING[CANADA NEWSWIRE]
Bulletins  30/Jul/2020  Delist
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data